Table 1 Baseline characteristics of the enrolled patients with type 2 diabetes in both groups
Characteristics | Cholecystectomy (n = 40) | Control (n = 37) | p value |
|---|---|---|---|
Age (years) | 55.9 ± 14.4 | 51.2 ± 12.0 | 0.125 |
Male/Female (n) | 17/23 | 19/18 | 0.583 |
BMI (kg/m2) | 24.4 ± 3.3 | 25.2 ± 3.0 | 0.287 |
Food intake (kcal) | 1925.4 ± 458.2 | 2015.3 ± 369.1 | 0.349 |
Duration of diabetes (month) | 20.9 ± 12.9 | 19.9 ± 13.6 | 0.726 |
TBA (μmol/L) | 3.3 ± 2.2 | 3.3 ± 2.9 | 0.987 |
REE (kcal) | 1292.0 ± 260.4 | 1353.0 ± 315.6 | 0.356 |
FAT (%) | 57.0 ± 19.0 | 54.2 ± 19.8 | 0.530 |
CHO (%) | 43.5 ± 18.9 | 46.3 ± 19.8 | 0.522 |
FPG (mmol/L) | 5.7 ± 1.4 | 5.6 ± 1.4 | 0.891 |
A1C (%, mmol/mol) | 6.0 ± 1.2 (42.2 ± 11.1) | 6.0 ± 1.3 (41.9 ± 13.2) | 0.935 |
Insulin (uIU/ml) | 10.0 ± 4.9 | 10.3 ± 5.9 | 0.831 |
C-peptide (ng/ml) | 1.5 ± 0.6 | 1.6 ± 0.7 | 0.817 |
HOMA-IR | 2.5 ± 1.6 | 3.1 ± 2.2 | 0.179 |
HOMA-β | 124.5 ± 92.8 | 123.6 ± 58.9 | 0.960 |
TC (mmol/L) | 4.8 ± 1.0 | 4.7 ± 0.9 | 0.732 |
TG (mmol/L) | 1.4 ± 0.7 | 1.5 ± 0.8 | 0.656 |
HDL-C (mmol/L) | 1.2 ± 0.3 | 1.1 ± 0.2 | 0.080 |
LDL-C (mmol/L) | 3.0 ± 1.0 | 3.0 ± 0.8 | 0.827 |
Anti-diabetic medicine | |||
Insulin/OHA (n) | 17/23 | 15/22 | 0.862 |